Higher risk for cardiovascular mortality, kidney disease progression seen with serum 25(OH)D <10 ng/mL. (HealthDay News) — Vitamin D deficiency is associated with increased risks for cardiovascular ...

“[K]etoconazole-containing regimens are effective and safe for the treatment of castration-resistant prostate cancer,” researchers wrote. Results of a meta-analysis support the use of ketoconazole for ...

Many women with CKD in the US receive suboptimal care that is out of step with guidelines. Contemporary studies continue to document disparities in guideline-based care for women with chronic kidney ...

Benzbromarone demonstrated slightly greater efficacy for the rapid reduction of serum uric acid levels and offered greater anti-inflammatory effects vs febuxostat for the treatment of gout and ...

V1421 carriers have an increased risk for heart failure hospitalization. (HealthDay News) — Male and female V1421 carriers face a similar and substantial risk for heart failure hospitalization, ...

Credit: Getty Images The “Health Industry Cybersecurity Strategic Plan” debuts amid the most serious cyberattack on the US health care system in American history. Cybersecurity needs to be an ...

Credit: Thinkstock Patients with CKD also should reduce intake of ultra-processed foods. Latest update gives greater weight to the significance of diet in managing chronic kidney disease. The Kidney ...

US veterans who transition to dialysis are 22% and 43% less likely to be referred to palliative and hospital care, respectively, than those managed conservatively. Patients with advanced chronic ...

(HealthDay News) — For kidney transplant (KT) candidates with obesity, sleeve gastrectomy (SG) is effective, and a considerable proportion of patients undergo KT within 20.9 months, according to ...

Bicarbonate use vs nonuse by patients with incident CKD is associated with a 1.5-fold higher risk for incident end-stage kidney disease in a fully adjusted model. Oral bicarbonate use by patients ...

AB-1002 is administered via antegrade intracoronary artery infusion. The Food and Drug Administration (FDA) has granted Fast Track designation to AB-1002 for the treatment of congestive heart ...

Use of sodium zirconium cyclosilicate for more than 90 days is associated with a lower risk for hyperkalemia-related hospitalizations and emergency department visits compared with 30 or fewer days ...